171 related articles for article (PubMed ID: 3436106)
21. Cholinotoxicity induced by ethylcholine aziridinium ion after intracarotid and intracerebroventricular administration.
Pittel Z; Fisher A; Heldman E
Life Sci; 1989; 44(20):1437-48. PubMed ID: 2725177
[TBL] [Abstract][Full Text] [Related]
22. Ultrastructural and neurochemical effects of the presumed cholinergic toxin AF64A in the rat interpeduncular nucleus.
Villani L; Contestabile A; Migani P; Poli A; Fonnum F
Brain Res; 1986 Aug; 379(2):223-31. PubMed ID: 3742221
[TBL] [Abstract][Full Text] [Related]
23. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A).
Hörtnagl H; Berger ML; Havelec L; Hornykiewicz O
J Neurosci; 1993 Jul; 13(7):2939-45. PubMed ID: 7687281
[TBL] [Abstract][Full Text] [Related]
24. Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats.
Hiramatsu M; Yamatsu T; Kameyama T; Nabeshima T
J Neural Transm (Vienna); 2002 Mar; 109(3):361-75. PubMed ID: 11956957
[TBL] [Abstract][Full Text] [Related]
25. Noradrenaline depletion protects cholinergic neurons in rat hippocampus against AF64A-induced damage.
Hörtnagl H; Potter PE; Kindel G; Hanin I
J Neurosci Methods; 1989 Mar; 27(2):103-8. PubMed ID: 2709878
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal electrical activity in relation to behavior following ethylcholine aziridinium ion (AF64A) treatment.
Stewart DJ; Leventer SM; Hanin I; Vanderwolf CH
Pharmacol Biochem Behav; 1987 Feb; 26(2):357-64. PubMed ID: 3575356
[TBL] [Abstract][Full Text] [Related]
27. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
Vickroy TW; Watson M; Leventer SM; Roeske WR; Hanin I; Yamamura HI
J Pharmacol Exp Ther; 1985 Dec; 235(3):577-82. PubMed ID: 3841155
[TBL] [Abstract][Full Text] [Related]
28. Effect of cholinergic deficit induced by ethylcholine aziridinium on serotonergic parameters in rat brain.
Hörtnagl H; Potter PE; Hanin I
Neuroscience; 1987 Jul; 22(1):203-13. PubMed ID: 2442662
[TBL] [Abstract][Full Text] [Related]
29. Effects of intrastriatal injections of the cholinergic neurotoxin AF64A on spontaneous nocturnal locomotor behavior in the rat.
Sandberg K; Sanberg PR; Coyle JT
Brain Res; 1984 May; 299(2):339-43. PubMed ID: 6329420
[TBL] [Abstract][Full Text] [Related]
30. Specific toxic effects of ethylcholine nitrogen mustard on cholinergic neurons of the nucleus basalis of Meynert.
Kozlowski MR; Arbogast RE
Brain Res; 1986 Apr; 372(1):45-54. PubMed ID: 3708359
[TBL] [Abstract][Full Text] [Related]
31. The AF64a-treated mouse: possible model for central cholinergic hypofunction.
Mantione CR; Fisher A; Hanin I
Science; 1981 Jul; 213(4507):579-80. PubMed ID: 6894649
[TBL] [Abstract][Full Text] [Related]
32. Alpha-sialyl cholesterol reverses AF64A-induced deficit in passive avoidance response and depletion of hippocampal acetylcholine in mice.
Abe E; Murai S; Masuda Y; Saito H; Itoh T
Br J Pharmacol; 1993 Feb; 108(2):387-92. PubMed ID: 8448588
[TBL] [Abstract][Full Text] [Related]
33. AF64A produces long-term cognitive impairments following infusion into the lateral cerebral ventricles or the dorsal hippocampus: involvement of hippocampal cholinergic processes in learning and memory.
Walsh TJ; Chrobak JJ; Tilson HA; Dehaven DL; Hanin I
Ann N Y Acad Sci; 1985; 444():538-40. PubMed ID: 3925852
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and behavioral effects of intrahippocampal AF64A in rats.
Blaker WD; Goodwin SD
Pharmacol Biochem Behav; 1987 Oct; 28(2):157-63. PubMed ID: 3685051
[TBL] [Abstract][Full Text] [Related]
35. AF64A(ethylcholine aziridinium ion)-induced basal forebrain lesion impairs maze performance.
Nakamura S; Nakagawa Y; Kawai M; Tohyama M; Ishihara T
Behav Brain Res; 1988 Jul; 29(1-2):119-26. PubMed ID: 3401315
[TBL] [Abstract][Full Text] [Related]
36. Effects of intracerebroventricular AF64A administration on cholinergic, serotoninergic and catecholaminergic circuitry in rat dorsal hippocampus.
Gaál G; Potter PE; Hanin I; Kakucska I; Vizi ES
Neuroscience; 1986 Dec; 19(4):1197-205. PubMed ID: 2881229
[TBL] [Abstract][Full Text] [Related]
37. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl.
Ricci A; Mancini M; Strocchi P; Bongrani S; Bronzetti E
Drugs Exp Clin Res; 1992; 18(5):163-71. PubMed ID: 1490432
[TBL] [Abstract][Full Text] [Related]
38. Selective cholinergic neurotoxin: AF64A's effects in rat striatum.
Sandberg K; Hanin I; Fisher A; Coyle JT
Brain Res; 1984 Feb; 293(1):49-55. PubMed ID: 6142754
[TBL] [Abstract][Full Text] [Related]
39. Passive avoidance deficits in mice following ethylcholine aziridinium chloride treatment.
Pope CN; Englert LF; Ho BT
Pharmacol Biochem Behav; 1985 Feb; 22(2):297-9. PubMed ID: 3983221
[TBL] [Abstract][Full Text] [Related]
40. The cholinergic neurotoxin ethylcholine mustard aziridinium (AF64A) induces an increase in MAO-B activity in the rat brain.
Jossan SS; Hiraga Y; Oreland L
Brain Res; 1989 Jan; 476(2):291-7. PubMed ID: 2702470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
